1. Home
  2. ABEV vs MDLN Comparison

ABEV vs MDLN Comparison

Compare ABEV & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambev S.A.

ABEV

Ambev S.A.

HOLD

Current Price

$2.90

Market Cap

47.1B

ML Signal

HOLD

MDLN

Medline Inc. Class A Common Stock

HOLD

Current Price

$34.68

Market Cap

37.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEV
MDLN
Founded
1885
1966
Country
Brazil
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.1B
37.4B
IPO Year
2012
2025

Fundamental Metrics

Financial Performance
Metric
ABEV
MDLN
Price
$2.90
$34.68
Analyst Decision
Sell
Strong Buy
Analyst Count
4
23
Target Price
$2.94
$50.48
AVG Volume (30 Days)
35.6M
7.0M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
4.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.23
Revenue
N/A
$28,432,000,000.00
Revenue This Year
$7.96
$10.88
Revenue Next Year
$5.35
$7.69
P/E Ratio
$16.99
$148.96
Revenue Growth
N/A
11.47
52 Week Low
$2.10
$32.49
52 Week High
$3.45
$50.88

Technical Indicators

Market Signals
Indicator
ABEV
MDLN
Relative Strength Index (RSI) 46.37 43.08
Support Level $2.84 $33.52
Resistance Level $3.24 $43.31
Average True Range (ATR) 0.06 1.60
MACD 0.00 -0.17
Stochastic Oscillator 48.48 39.22

Price Performance

Historical Comparison
ABEV
MDLN

About ABEV Ambev S.A.

Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.

About MDLN Medline Inc. Class A Common Stock

Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

Share on Social Networks: